Filed: 2/14/2024ACC: 0000905148-24-000724
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $667.20M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$667.20M
Total AUM (reported)
30.34M
Total Shares
Allocation by class
COM$667.20M100.0%
Portfolio Concentration
Top 3$603.11M90.4%
4–10$64.09M9.6%
Top 3 weight
90.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 30.34M
Sole
Full voting authority
30.34M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
RAYZEBIO INC
SOLEShares5.16M
TypeSH
Market value$320.68M
48.06%
Sole
5.16M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$144.43M
21.65%
Sole
9.70M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares4.92M
TypeSH
Market value$137.99M
20.68%
Sole
4.92M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.04M
TypeSH
Market value$33.44M
5.01%
Sole
1.04M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.85M
TypeSH
Market value$28.74M
4.31%
Sole
3.85M
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.91M
TypeSH
Market value$1.56M
0.23%
Sole
2.91M
Shared
0.00
None
0.00
IMPEL PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$340.8K
0.05%
Sole
2.76M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RAYZEBIO INCSOLE | COM | 5.16M | SH | $320.68M 48.06% | 5.16M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $144.43M 21.65% | 9.70M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 4.92M | SH | $137.99M 20.68% | 4.92M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.04M | SH | $33.44M 5.01% | 1.04M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.85M | SH | $28.74M 4.31% | 3.85M | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.91M | SH | $1.56M 0.23% | 2.91M | 0.00 | 0.00 |
IMPEL PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $340.8K 0.05% | 2.76M | 0.00 | 0.00 |